How SCHEMA helps patients access rare disease treatments

Over 30-million Americans have been diagnosed with a rare disease, however only 10% of these conditions have an FDA approved treatment option. The good news is that there are over 700 drugs in the #pharma pipeline targeting rare diseases. Despite the promising new treatments on the way, significant hurdles will inevitably hinder patients from accessing newly approved drugs. At SCHEMA, we focus on helping to overcome these barriers and expedite patient #access to these essential treatments. #SCHEMACares4Rare #CareForRare #RareDisease